Cerebellar atrophy — the deterioration of nerve cells in the cerebellum — is a rare but serious manifestation of primary Sjogren’s syndrome, according to a new case study from Iran. The report, “Cerebellar degeneration in primary Sjogren syndrome,” was published in the journal BMJ Case Reports. Sjogren’s…
Yeast colonization in the oral cavity of patients with Sjogren’s syndrome follows a different pattern compared to healthy people, suggesting a reason why some patients respond better to commonly prescribed antifungal agents compared with others, a new study shows. The study, “Oral yeast colonization in patients with…
Musculoskeletal ultrasound is better than clinical examination and blood tests for the best management of hand arthritis in Sjogren’s syndrome patients, according to a new study. The findings were presented recently at the European Lupus Meeting 2018, in Düsseldorf, Germany, in an abstract titled “PS6:120 Hand ultrasound guided therapeutic decisions…
Treatment with ciclosporin A — an anti-inflammatory medication — significantly improved the signs and symptoms of patients with moderate-to-severe dry eye disease (DED), including those with Sjögren’s syndrome, an analysis of two Phase 3 studies shows. The study, “Efficacy and safety of 0.1% ciclosporin A cationic emulsion in…
Autophagy — a physiological process that involves the destruction of old or diseased cells in the body, maintaining normal functions by protein degradation — is impaired in the salivary glands of patients with Sjogren’s syndrome, but may be corrected through the use of a potential therapy called P140 peptide, according…
Get regular updates to your inbox.